NIH, 11 biopharmaceutical companies partner to speed development of cancer immunotherapy strategies. The National Institutes of Health and 11 leading biopharmaceutical companies Thursday launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and…